Vestcor Inc’s Vanda Pharmaceuticals VNDA Stock Holding History

Vestcor Inc’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,285	Closed	-$19K	–	1307
2023 Q3	$19K	Buy	+4,285	New	+$23.8K	﹤0.01%	1204

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Vestcor Inc's VNDA Position: Q4 2023 in Review

Vestcor Inc sold out of Vanda Pharmaceuticals (VNDA) in Q4 2023, closing a stake of 4,285 shares — an estimated $19K sold.

Vestcor Inc first reported a position in VNDA in Q3 2023 and held it in 1 quarter. The position peaked at $19K in Q3 2023. 157 funds tracked by Wall St. Rank hold VNDA as of Q4 2023.

Vestcor Inc reported no remaining Vanda Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Vestcor Inc sold 4,285 Vanda Pharmaceuticals shares in Q4 2023, an estimated $19K.
Vestcor Inc first reported a position in Vanda Pharmaceuticals in Q3 2023 and held it in 1 quarter.
Vestcor Inc's Vanda Pharmaceuticals position peaked at $19K in Q3 2023.
157 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2023.

Based on Vestcor Inc's 13F filing for Q4 2023, filed 14 Feb 2024.